Patents by Inventor Adam Inglis

Adam Inglis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for preparation of amino acid thiohydantoins
    Patent number: 5756667
    Abstract: The present invention consists in a method of preparing amino thiohydantoins either in isolation or as the C-terminals residue of a peptide. The method comprises reacting the amino acid or peptide with an acylating agent and thiocyanate or isothiocyanates in the presence of a strong acid. The present invention also relates to an improved method for C-terminal sequencing of peptides which routinely analyses all of the common amino acids of peptides. The invention involves the use of a strong, volatile, anhydrous organic or mineral acid to cleave the terminal amino acid thiohydantoin.
    Type: Grant
    Filed: September 23, 1994
    Date of Patent: May 26, 1998
    Assignee: Garvan Institute of Medical Research
    Inventors: Adam Inglis, Albert Peng Sheng Tseng, Peter Laurence Adams
  • PLA.sub.2 inhibitory compounds
    Patent number: 5656602
    Abstract: The present invention provides peptides and compounds which inhibit the enzyme activity of Type II phospholipases A.sub.2. The preferred compounds are pentapeptides. Where the phospholipase is human Type II phospholipase A.sub.2 the preferred peptides are FLSYK and KFLSY.
    Type: Grant
    Filed: March 3, 1994
    Date of Patent: August 12, 1997
    Assignee: Garvan Institute of Medical Research
    Inventors: Albert Peng Sheng Tseng, Adam Inglis, Kieran Scott